Re:Opaque drug pricing in the U.S.
by cle on Sunday March 12, 2017 @04:48PM
(#13853013)
One reason would be if pharma has a sufficiently larger margin than hospitals and doctors. It might be the case that there's more to save in that 10% than the rest of the 90% (especially when the cost of implementing change is considered).
[ Parent
| on HN ]
Yes, but if you cut the cost in half you would be saving 5% of the overall. We all know there is far more than 5% savings in the 90% piece.